Soleno Therapeutics Inc (SLNO)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
29-Jan-24 5:44 PM
View: 
Hirano Patricia C
See Remarks
Soleno Therapeutics Inc (SLNO) 25-Jan-24Private Sale 832$48.30$40,185.60(2%)
43.97K to 43.14K
29-Jan-24 5:47 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 25-Jan-24Private Sale 397$48.30$19,175.10(2%)
26.04K to 25.64K
29-Jan-24 5:42 PM
View: 
Anish Bhatnagar
Chief Executive Officer
Director
Soleno Therapeutics Inc (SLNO) 25-Jan-24Private Sale 2,527$48.30$122,054.00(1%)
174.3K to 171.77K
10-Jan-24 4:31 PM
View: 
Mario Ernest
Director
Soleno Therapeutics Inc (SLNO) 08-Jan-24Gift 3,523----(2%)
148.84K to 145.32K
08-Jan-24 5:35 PM
View: 
Hirano Patricia C
See Remarks
Soleno Therapeutics Inc (SLNO) 04-Jan-24Grant 24,000----120%
19.97K to 43.97K
08-Jan-24 5:37 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 04-Jan-24Grant 24,000----1178%
2.04K to 26.04K
08-Jan-24 5:34 PM
View: 
Anish Bhatnagar
Chief Executive Officer
Director
Soleno Therapeutics Inc (SLNO) 04-Jan-24Grant 150,000----617%
24.3K to 174.3K
08-Jan-24 5:36 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 04-Jan-24Grant 56,000----462%
12.13K to 68.13K
15-Dec-23 6:00 PM
View: 
Hirano Patricia C
See Remarks
Soleno Therapeutics Inc (SLNO) 14-Dec-23Sale 1,359$36.49$49,583.50(6%)
21.33K to 19.97K
14-Dec-23 7:57 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 13-Dec-23Sale 13,333$37.76$503,490.00(87%)
15.37K to 2.04K
15-Dec-23 6:00 PM
View: 
Hirano Patricia C
See Remarks
Soleno Therapeutics Inc (SLNO) 13-Dec-23Private Sale 4,885$38.79$189,513.00(19%)
26.22K to 21.33K
14-Dec-23 7:57 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 13-Dec-23Option Exercise 17,916$2.55$45,644.20880%
2.04K to 19.95K
14-Dec-23 7:57 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 13-Dec-23Option Sale 4,583$37.76$173,066.00(23%)
19.95K to 15.37K
14-Dec-23 7:57 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 12-Dec-23Sale 6,580$36.95$243,160.00(76%)
8.62K to 2.04K
14-Dec-23 7:57 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 12-Dec-23Private Option Sale 13,333$36.95$492,714.00(61%)
21.95K to 8.62K
13-Dec-23 9:34 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 11-Dec-23Option Sale 15,000$36.41$546,223.00(34%)
44.61K to 29.61K
13-Dec-23 9:34 PM
View: 
Anish Bhatnagar
Chief Executive Officer
Director
Soleno Therapeutics Inc (SLNO) 11-Dec-23Private Sale 93,408$35.67$3,331,700.00(79%)
117.7K to 24.3K
13-Dec-23 9:34 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 11-Dec-23Sale 17,482$36.41$636,605.00(59%)
29.61K to 12.13K
13-Dec-23 9:34 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 11-Dec-23Option Exercise 15,000$2.60$38,925.0051%
29.61K to 44.61K
04-Dec-23 8:03 PM
View: 
Hirano Patricia C
See Remarks
Soleno Therapeutics Inc (SLNO) 30-Nov-23Private Sale 3,823$28.65$109,536.00(13%)
30.04K to 26.22K
04-Dec-23 8:41 PM
View: 
Mario Ernest
Director
Soleno Therapeutics Inc (SLNO) 30-Nov-23Gift 8,700----(6%)
157.54K to 148.84K
04-Dec-23 8:06 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 30-Nov-23Private Sale 3,963$28.65$113,547.00(15%)
25.91K to 21.95K
04-Dec-23 8:04 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 30-Nov-23Private Sale 4,186$28.65$119,937.00(16%)
25.49K to 21.3K
04-Dec-23 8:02 PM
View: 
Anish Bhatnagar
Chief Executive Officer
Director
Soleno Therapeutics Inc (SLNO) 30-Nov-23Private Sale 27,716$28.65$794,116.00(20%)
135.78K to 108.06K
30-Nov-23 9:52 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 29-Nov-23Sale 3,979$27.83$110,751.00(13%)
29.89K to 25.91K
30-Nov-23 9:52 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 29-Nov-23Sale 4,203$27.83$116,986.00(14%)
29.69K to 25.49K
30-Nov-23 9:50 PM
View: 
Anish Bhatnagar
Chief Executive Officer
Director
Soleno Therapeutics Inc (SLNO) 29-Nov-23Sale 27,827$27.83$774,535.00(17%)
163.6K to 135.78K
30-Nov-23 9:51 PM
View: 
Hirano Patricia C
See Remarks
Soleno Therapeutics Inc (SLNO) 29-Nov-23Sale 3,839$27.83$106,855.00(11%)
33.88K to 30.04K
30-Nov-23 9:52 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 28-Nov-23Private Sale 3,878$27.12$105,190.00(12%)
33.57K to 29.69K
30-Nov-23 9:50 PM
View: 
Anish Bhatnagar
Chief Executive Officer
Director
Soleno Therapeutics Inc (SLNO) 28-Nov-23Private Sale 25,678$27.12$696,514.00(14%)
189.28K to 163.6K
30-Nov-23 9:51 PM
View: 
Hirano Patricia C
See Remarks
Soleno Therapeutics Inc (SLNO) 28-Nov-23Private Sale 3,542$27.12$96,076.50(9%)
37.42K to 33.88K
30-Nov-23 9:52 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 28-Nov-23Private Sale 3,671$27.12$99,575.40(11%)
33.56K to 29.89K
13-Dec-23 9:32 PM
View: 
Anish Bhatnagar
Chief Executive Officer
Director
Soleno Therapeutics Inc (SLNO) 20-Oct-23Option Exercise 9,643$3.16$30,500.305%
189.28K to 198.93K
13-Dec-23 9:32 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 02-Oct-23Option Exercise 8,309$2.95$24,497.2025%
33.57K to 41.88K
04-Oct-23 4:30 PM
View: 
Vivo Opportunity, LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 02-Oct-23Exercise (in-the money or at-the-money) 5,215,000$2.50$13,037,500.00163%
3.2M to 8.42M
02-Oct-23 10:00 PM
View: 
Carlyle Group L.P.
10% Owner
Soleno Therapeutics Inc (SLNO) 28-Sep-23Conversion 329,930$1.75$577,378.0027%
1.2M to 1.53M
28-Sep-23 3:45 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 28-Sep-23Purchase 250,000$20.00$5,000,000.009%
2.82M to 3.07M
28-Sep-23 3:45 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 26-Sep-23Purchase 616,789$16.40$10,113,900.0028%
2.21M to 2.82M
28-Sep-23 5:00 PM
View: 
Vivo Opportunity, LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 26-Sep-23Exercise (in-the money or at-the-money) 3,203,090$1.75$5,605,410.00100%
0 to 3.2M
06-Jun-23 4:16 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 06-Jun-23Purchase 200$5.93$1,186.00< 1%
2.21M to 2.21M
06-Jun-23 4:16 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 05-Jun-23Purchase 78,468$5.98$469,239.004%
2.13M to 2.21M
06-Jun-23 4:16 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 02-Jun-23Purchase 64,630$5.93$383,256.003%
2.06M to 2.13M
01-Jun-23 5:41 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 01-Jun-23Purchase 7,500$5.59$41,925.00< 1%
2.06M to 2.06M
01-Jun-23 5:41 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 31-May-23Purchase 10,000$5.28$52,800.00< 1%
2.05M to 2.06M
01-Jun-23 5:41 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 30-May-23Purchase 17,500$5.34$93,450.00< 1%
2.03M to 2.05M
26-May-23 6:28 PM
View: 
Hirano Patricia C
See Remarks
Soleno Therapeutics Inc (SLNO) 26-May-23Grant 28,149----304%
9.27K to 37.42K
26-May-23 6:28 PM
View: 
MacKaness James H
Chief Financial Officer
Soleno Therapeutics Inc (SLNO) 26-May-23Grant 29,084----648%
4.49K to 33.57K
26-May-23 6:39 PM
View: 
Yen Kristen
See Remarks
Soleno Therapeutics Inc (SLNO) 26-May-23Grant 29,131----657%
4.43K to 33.56K
26-May-23 6:26 PM
View: 
Anish Bhatnagar
Chief Executive Officer
Director
Soleno Therapeutics Inc (SLNO) 26-May-23Grant 160,602----560%
28.68K to 189.28K
26-May-23 5:57 PM
View: 
Perceptive Advisors LLC
10% Owner
Soleno Therapeutics Inc (SLNO) 26-May-23Purchase 22,500$5.27$118,575.001%
2.01M to 2.03M